JP2005502644A5 - - Google Patents

Download PDF

Info

Publication number
JP2005502644A5
JP2005502644A5 JP2003518554A JP2003518554A JP2005502644A5 JP 2005502644 A5 JP2005502644 A5 JP 2005502644A5 JP 2003518554 A JP2003518554 A JP 2003518554A JP 2003518554 A JP2003518554 A JP 2003518554A JP 2005502644 A5 JP2005502644 A5 JP 2005502644A5
Authority
JP
Japan
Prior art keywords
lower alkyl
phenyl
oxo
benzo
yloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003518554A
Other languages
English (en)
Japanese (ja)
Other versions
JP4364637B2 (ja
JP2005502644A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/008523 external-priority patent/WO2003013545A1/en
Publication of JP2005502644A publication Critical patent/JP2005502644A/ja
Publication of JP2005502644A5 publication Critical patent/JP2005502644A5/ja
Application granted granted Critical
Publication of JP4364637B2 publication Critical patent/JP4364637B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003518554A 2001-08-09 2002-07-31 新規なベンゾ縮合へテロ環化合物 Expired - Fee Related JP4364637B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0109235 2001-08-09
PCT/EP2002/008523 WO2003013545A1 (en) 2001-08-09 2002-07-31 Novel benzo-fused heterocycles as endothelin antagonisits

Publications (3)

Publication Number Publication Date
JP2005502644A JP2005502644A (ja) 2005-01-27
JP2005502644A5 true JP2005502644A5 (cg-RX-API-DMAC7.html) 2006-01-12
JP4364637B2 JP4364637B2 (ja) 2009-11-18

Family

ID=8164539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003518554A Expired - Fee Related JP4364637B2 (ja) 2001-08-09 2002-07-31 新規なベンゾ縮合へテロ環化合物

Country Status (15)

Country Link
US (1) US7238685B2 (cg-RX-API-DMAC7.html)
JP (1) JP4364637B2 (cg-RX-API-DMAC7.html)
KR (1) KR100909122B1 (cg-RX-API-DMAC7.html)
CN (1) CN100418955C (cg-RX-API-DMAC7.html)
AR (1) AR036386A1 (cg-RX-API-DMAC7.html)
AU (1) AU2002328999B8 (cg-RX-API-DMAC7.html)
BR (1) BR0211729A (cg-RX-API-DMAC7.html)
CA (1) CA2454417A1 (cg-RX-API-DMAC7.html)
HU (1) HUP0401107A3 (cg-RX-API-DMAC7.html)
IL (1) IL159963A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04001252A (cg-RX-API-DMAC7.html)
NO (1) NO20040563L (cg-RX-API-DMAC7.html)
NZ (1) NZ530741A (cg-RX-API-DMAC7.html)
WO (1) WO2003013545A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200400803B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101792651B1 (ko) 2004-05-14 2017-11-20 밀레니엄 파머슈티컬스 인코퍼레이티드 아우로라 키나아제의 억제에 의해 유사분열 진행을 억제하기 위한 화합물 및 그 화합물을 포함하는 약학적 조성물
WO2008021038A2 (en) 2006-08-09 2008-02-21 Millennium Pharmaceuticals, Inc. Pyridobenzazepine compounds and methods for inhibiting mitotic progression
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
EP2123644B1 (en) 2007-03-07 2014-12-17 Takeda Pharmaceutical Company Limited Benzoxazepine derivatives and use thereof
BRPI0811204A8 (pt) * 2007-05-10 2015-09-22 Bristol Myers Squibb Co Tetra-hidroibenzo-1,4-diazepinas substituídas por arila e heteroarila e uso das mesmas para bloquear a recaptação de norepinefrina, dopamina e serotonina
EA201000046A1 (ru) * 2007-06-21 2011-02-28 Кара Терапеутикс, Инк. Замещенные имидазогетероциклы
US8119629B2 (en) 2007-10-03 2012-02-21 Bristol-Meyers Squibb Company Carboxamide GABAA α2 modulators
WO2010068520A2 (en) * 2008-12-11 2010-06-17 Cara Therapeutics, Inc. Substituted imidazoheterocycle derivatives
CN102264368B (zh) 2008-12-22 2014-09-10 米伦纽姆医药公司 极光激酶抑制剂与抗cd20抗体的组合
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
WO2011103089A1 (en) 2010-02-19 2011-08-25 Millennium Pharmaceuticals, Inc. Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6--methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate
CN101805283B (zh) * 2010-03-23 2013-01-02 渤海大学 含薁类结构的1,4-二氢吡啶类化合物及其制备方法
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
EP2976086B1 (en) 2013-03-22 2020-10-14 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
EP3324976A4 (en) 2015-07-21 2019-03-27 Millennium Pharmaceuticals, Inc. ADMINISTRATION OF KINASE AURORA INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
CN112939855B (zh) * 2021-02-08 2024-03-26 马鞍山市泰博化工科技有限公司 一种制备含有薁环结构的1,4-二氢吡啶衍生物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614498A (en) * 1990-06-07 1997-03-25 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic substance
US5420123A (en) * 1992-12-21 1995-05-30 Bristol-Myers Squibb Company Dibenzodiazepine endothelin antagonists
PL182011B1 (en) * 1993-08-26 2001-10-31 Yamanouchi Pharma Co Ltd Benzazepine derivative, pharmaceutic composition and intermediate compounds
JP2000143636A (ja) * 1998-09-02 2000-05-26 Sumitomo Pharmaceut Co Ltd アミノ誘導体

Similar Documents

Publication Publication Date Title
US11304946B2 (en) 2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists
JP4753403B2 (ja) インテグリンのそのレセプターへの結合を阻害する化合物
US11040035B2 (en) 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
JP5600754B2 (ja) ピラジン誘導体および神経障害の処置におけるそれらの使用
EP2421852B1 (en) Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
JP2023506642A5 (cg-RX-API-DMAC7.html)
US9586961B2 (en) Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
RS52175B (sr) Hidroksimetil pirolidini kao agonisti beta 3 adrenergičkog receptora
TW201211038A (en) Oxazine derivatives and their use in the treatment of neurological disorders
JP2019536757A5 (cg-RX-API-DMAC7.html)
JP2012255004A (ja) ヒドロキシステロイドデヒドロゲナーゼ阻害剤
RU2008141510A (ru) Новые соединения
JP2013532713A5 (cg-RX-API-DMAC7.html)
CN1265585A (zh) (咪唑-5-基)甲基-2-喹啉酮衍生物用作平滑肌细胞增殖抑制剂
US20170044183A1 (en) FACTOR XIa INHIBITORS
HUP0202184A2 (hu) Integrinek receptoraikhoz való kötődését gátló propánsavszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
RU2015103119A (ru) Антипролиферативные бензо[в]азепин-2-оны
JP2021535137A5 (cg-RX-API-DMAC7.html)
RU2008108939A (ru) Замещенные имидазолы, фармацевтическая композиция, способ лечения заболевания, связанного по крайней мере с активностью ksp, способ ингибирования ksp, лекарственное средство для лечения рака
EP4178620B1 (en) Plasma kallikrein inhibitors
JP2005528459A5 (cg-RX-API-DMAC7.html)
US20180030036A1 (en) Factor IXa Inhibitors
KR20140037195A (ko) 신규 프탈라지논-피롤로피리미딘카복스아미드 유도체
US9914727B2 (en) Factor IXa inhibitors
HUP0402357A2 (hu) Antihisztaminok alkalmazása megnövelt koponyán belüli nyomás akut csökkentésére és gyógyszerkészítmények előállítására